News stories about Aetna (NYSE:AET) have been trending somewhat positive this week, according to Accern. The research firm scores the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Aetna earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave news articles about the company an impact score of 44.276327388547 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:
- Recent Insiders Bustle: Aetna Inc. (AET), Valero Energy Corporation (VLO) – Market Movers (financialqz.com)
- Aetna Inc (AET) Expected to Post Quarterly Sales of $14.89 Billion (americanbankingnews.com)
- Form 4 AETNA INC /PA/ For: Dec 11 Filed by: SOISTMAN FRANCIS S JR (streetinsider.com)
- How a CVS-Aetna merger could change the health care scene in Louisville (bizjournals.com)
- No immediate changes foreseen in Expatland after acquisition of Aetna Int’l parent by US drugstore chain – International Investment (internationalinvestment.net)
Several equities research analysts have recently weighed in on AET shares. Wells Fargo & Company reiterated an “outperform” rating and issued a $208.00 price target (up from $200.00) on shares of Aetna in a report on Monday, December 4th. Credit Suisse Group started coverage on Aetna in a research report on Thursday, November 2nd. They set a “neutral” rating and a $174.00 target price on the stock. Zacks Investment Research cut Aetna from a “buy” rating to a “hold” rating in a research report on Monday, October 16th. Raymond James Financial raised Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 target price on the stock in a research report on Friday, November 3rd. Finally, BMO Capital Markets initiated coverage on Aetna in a research report on Monday, October 16th. They issued a “market perform” rating and a $175.00 price objective for the company. Twelve equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $175.19.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping the consensus estimate of $2.06 by $0.39. The business had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.07 earnings per share. sell-side analysts forecast that Aetna will post 9.78 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s dividend payout ratio (DPR) is 37.04%.
In other news, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
What are top analysts saying about Aetna? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna and related companies.